Logo image of LIVN

LIVANOVA PLC (LIVN) Stock Fundamental Analysis

NASDAQ:LIVN - Nasdaq - GB00BYMT0J19 - Common Stock - Currency: USD

41.72  +0.02 (+0.05%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to LIVN. LIVN was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of LIVN get a neutral evaluation. Nothing too spectacular is happening here. LIVN is cheap, but on the other hand it scores bad on growth. This makes LIVN very considerable for value investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

LIVN had positive earnings in the past year.
LIVN had a positive operating cash flow in the past year.
In the past 5 years LIVN reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: LIVN reported negative operating cash flow in multiple years.
LIVN Yearly Net Income VS EBIT VS OCF VS FCFLIVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M -300M

1.2 Ratios

LIVN has a better Return On Assets (0.94%) than 72.19% of its industry peers.
LIVN has a better Return On Equity (1.81%) than 74.33% of its industry peers.
LIVN has a better Return On Invested Capital (4.79%) than 77.54% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LIVN is significantly below the industry average of 8.04%.
The 3 year average ROIC (2.61%) for LIVN is below the current ROIC(4.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.94%
ROE 1.81%
ROIC 4.79%
ROA(3y)-3.07%
ROA(5y)-6.06%
ROE(3y)-5.42%
ROE(5y)-11.82%
ROIC(3y)2.61%
ROIC(5y)N/A
LIVN Yearly ROA, ROE, ROICLIVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20 -30

1.3 Margins

LIVN has a Profit Margin of 1.91%. This is in the better half of the industry: LIVN outperforms 72.73% of its industry peers.
LIVN has a better Operating Margin (10.74%) than 78.61% of its industry peers.
In the last couple of years the Operating Margin of LIVN has declined.
LIVN has a Gross Margin of 67.78%. This is in the better half of the industry: LIVN outperforms 74.33% of its industry peers.
In the last couple of years the Gross Margin of LIVN has remained more or less at the same level.
Industry RankSector Rank
OM 10.74%
PM (TTM) 1.91%
GM 67.78%
OM growth 3YN/A
OM growth 5Y-9.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.65%
GM growth 5Y0.15%
LIVN Yearly Profit, Operating, Gross MarginsLIVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LIVN is destroying value.
There is no outstanding debt for LIVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LIVN Yearly Shares OutstandingLIVN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
LIVN Yearly Total Debt VS Total AssetsLIVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

LIVN has an Altman-Z score of 1.62. This is a bad value and indicates that LIVN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of LIVN (1.62) is comparable to the rest of the industry.
The Debt to FCF ratio of LIVN is 5.76, which is a neutral value as it means it would take LIVN, 5.76 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LIVN (5.76) is better than 77.54% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that LIVN is not too dependend on debt financing.
LIVN has a Debt to Equity ratio of 0.46. This is comparable to the rest of the industry: LIVN outperforms 40.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 5.76
Altman-Z 1.62
ROIC/WACC0.57
WACC8.48%
LIVN Yearly LT Debt VS Equity VS FCFLIVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

LIVN has a Current Ratio of 3.37. This indicates that LIVN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.37, LIVN is in line with its industry, outperforming 59.36% of the companies in the same industry.
A Quick Ratio of 2.87 indicates that LIVN has no problem at all paying its short term obligations.
The Quick ratio of LIVN (2.87) is better than 62.03% of its industry peers.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 2.87
LIVN Yearly Current Assets VS Current LiabilitesLIVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.93%, which is quite good.
Measured over the past 5 years, LIVN shows a small growth in Earnings Per Share. The EPS has been growing by 1.82% on average per year.
EPS 1Y (TTM)19.93%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%-6.9%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.77%

3.2 Future

LIVN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.69% yearly.
Based on estimates for the next years, LIVN will show a small growth in Revenue. The Revenue will grow by 3.52% on average per year.
EPS Next Y9.91%
EPS Next 2Y9.47%
EPS Next 3Y11.09%
EPS Next 5Y10.69%
Revenue Next Year5.43%
Revenue Next 2Y5.4%
Revenue Next 3Y4.37%
Revenue Next 5Y3.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LIVN Yearly Revenue VS EstimatesLIVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
LIVN Yearly EPS VS EstimatesLIVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.38, which indicates a correct valuation of LIVN.
LIVN's Price/Earnings ratio is rather cheap when compared to the industry. LIVN is cheaper than 95.19% of the companies in the same industry.
LIVN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.43.
A Price/Forward Earnings ratio of 11.26 indicates a reasonable valuation of LIVN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LIVN indicates a rather cheap valuation: LIVN is cheaper than 96.26% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.65. LIVN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.38
Fwd PE 11.26
LIVN Price Earnings VS Forward Price EarningsLIVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

LIVN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LIVN is cheaper than 84.49% of the companies in the same industry.
88.77% of the companies in the same industry are more expensive than LIVN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.85
EV/EBITDA 14.33
LIVN Per share dataLIVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.25
PEG (5Y)6.82
EPS Next 2Y9.47%
EPS Next 3Y11.09%

More info and screens

0

5. Dividend

5.1 Amount

LIVN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIVANOVA PLC

NASDAQ:LIVN (2/26/2025, 12:37:51 PM)

41.72

+0.02 (+0.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)04-29 2025-04-29/bmo
Inst Owners104.09%
Inst Owner Change-93.42%
Ins Owners0.23%
Ins Owner Change0.16%
Market Cap2.27B
Analysts83.75
Price Target71.81 (72.12%)
Short Float %3.74%
Short Ratio4.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.78%
Min EPS beat(2)16.48%
Max EPS beat(2)23.08%
EPS beat(4)4
Avg EPS beat(4)24.36%
Min EPS beat(4)10.79%
Max EPS beat(4)47.07%
EPS beat(8)8
Avg EPS beat(8)20.91%
EPS beat(12)11
Avg EPS beat(12)14.81%
EPS beat(16)15
Avg EPS beat(16)25.79%
Revenue beat(2)2
Avg Revenue beat(2)3.23%
Min Revenue beat(2)2.68%
Max Revenue beat(2)3.78%
Revenue beat(4)4
Avg Revenue beat(4)4.03%
Min Revenue beat(4)2.68%
Max Revenue beat(4)5.89%
Revenue beat(8)8
Avg Revenue beat(8)4.49%
Revenue beat(12)10
Avg Revenue beat(12)3.07%
Revenue beat(16)13
Avg Revenue beat(16)2.94%
PT rev (1m)-0.42%
PT rev (3m)-0.28%
EPS NQ rev (1m)-0.55%
EPS NQ rev (3m)-0.55%
EPS NY rev (1m)0.69%
EPS NY rev (3m)-1.32%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 12.38
Fwd PE 11.26
P/S 1.82
P/FCF 20.85
P/OCF 14.31
P/B 1.73
P/tB 8.09
EV/EBITDA 14.33
EPS(TTM)3.37
EY8.08%
EPS(NY)3.7
Fwd EY8.88%
FCF(TTM)2
FCFY4.8%
OCF(TTM)2.92
OCFY6.99%
SpS22.87
BVpS24.13
TBVpS5.16
PEG (NY)1.25
PEG (5Y)6.82
Profitability
Industry RankSector Rank
ROA 0.94%
ROE 1.81%
ROCE 6.07%
ROIC 4.79%
ROICexc 5.69%
ROICexgc 12.83%
OM 10.74%
PM (TTM) 1.91%
GM 67.78%
FCFM 8.75%
ROA(3y)-3.07%
ROA(5y)-6.06%
ROE(3y)-5.42%
ROE(5y)-11.82%
ROIC(3y)2.61%
ROIC(5y)N/A
ROICexc(3y)2.98%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.31%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-25.61%
ROICexc growth 3YN/A
ROICexc growth 5Y-6.79%
OM growth 3YN/A
OM growth 5Y-9.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.65%
GM growth 5Y0.15%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 5.76
Debt/EBITDA 3.4
Cap/Depr 112.41%
Cap/Sales 4%
Interest Coverage 250
Cash Conversion 89.18%
Profit Quality 458.87%
Current Ratio 3.37
Quick Ratio 2.87
Altman-Z 1.62
F-Score8
WACC8.48%
ROIC/WACC0.57
Cap/Depr(3y)58.44%
Cap/Depr(5y)53.38%
Cap/Sales(3y)2.7%
Cap/Sales(5y)2.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.93%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%-6.9%
EPS Next Y9.91%
EPS Next 2Y9.47%
EPS Next 3Y11.09%
EPS Next 5Y10.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.77%
Revenue Next Year5.43%
Revenue Next 2Y5.4%
Revenue Next 3Y4.37%
Revenue Next 5Y3.52%
EBIT growth 1Y59.69%
EBIT growth 3YN/A
EBIT growth 5Y-8.51%
EBIT Next Year51.28%
EBIT Next 3Y22.99%
EBIT Next 5Y22.18%
FCF growth 1Y81.93%
FCF growth 3YN/A
FCF growth 5Y-13.51%
OCF growth 1Y86.89%
OCF growth 3YN/A
OCF growth 5Y-9.07%